Literature DB >> 6260828

Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography.

K P Flora, J C Cradock, J P Davignon.   

Abstract

A procedure for the determination of delta 9-tetrahydrocannabinol (delta 9-THC) in the presence of its degradation products in pharmaceutical vehicles by high-performance liquid chromatography (HPLC) is described. The method compares favorably with a standard gas-liquid chromatographic procedure used for the analysis of delta 9-THC in sesame oil USP. The HPLC method is suitable for quantitating delta 9-THC in the presence of several pharmaceutical vehicles and excipients including: sesame oil USP, polyvinylpyrrolidone, Emulphor EL620 and Cremophor EL. Extractions are not required and samples require little preparation. Only the addition of an internal standard in an appropriate solvent is necessary before injection. The procedure has been applied to stability studies of delta 9-THC in various pharmaceutical vehicles.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260828     DOI: 10.1016/s0021-9673(00)82611-4

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.

Authors:  Manish Munjal; Mahmoud A Elsohly; Michael A Repka
Journal:  J Pharm Sci       Date:  2006-11       Impact factor: 3.534

2.  Temperature stability and bioadhesive properties of delta9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems.

Authors:  Michael A Repka; Mahmoud A ElSohly; Manish Munjal; Samir A Ross
Journal:  Drug Dev Ind Pharm       Date:  2006-01       Impact factor: 3.225

3.  Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.

Authors:  Sridhar Thumma; Mahmoud A ElSohly; Shuang-Qing Zhang; Waseem Gul; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.